bioRxivCancer Biology
Trilliumosides A-B, two novel steroidal saponins isolated from Rhizomes of Trillium govanianum as potent anticancer agents targeting apoptosis in A-549 cancer cell line.
P. Gupta, B. A. Lone, M. Tabassum, A. Bhushan, U. Dhiman, D. Rani, P. N. Gupta, D. M. Mondhe, S. Gairola
Abstract
Two novel steroidal saponins, Trilliumosides A (1) and B (2) were isolated from the rhizomes of Trillium govanianum by bioactivity-guided phytochemical investigation along with seven known compounds protodioscin (3) govanoside B (4), borassoside E (5), 20-hydroxyecdysone (6), 5-20-hydroxyecdysone (7), govanic acid (8), and diosgenin (9). The structure of novel compounds 1-2 were established using spectroscopic methods such as 1D, 2D NMR data and HR-ESI-MS. The isolated compounds were evaluated for in-vitro cytotoxic activity against a panel of human cancer cell lines. Compound 1 showed significant cytotoxic activity against A-549 (Lung) and SW-620 (Colon) cell lines with IC50 values of 1.83 and 1.85 {micro}M, whereas compound (2) IC50 value against A-549 cell line was found to be 1.79 {micro}M. Among previously known compounds (3), (5) and (9) their cytotoxic IC50 value was found to be in the range of 5-10 {micro}M. In detailed anticancer analysis compound (2) was seen inhibiting colony forming potential and in-vitro migration in the A-549 cell line. Furthermore, the mechanistic study of compound (2) on the A-549 cell line revealed characteristic changes including nuclear morphology, increased ROS generation, and reduced levels of MMP. Above mentioned events eventually induce apoptosis, a key hallmark in cancer studies, by upregulating the pro-apoptotic protein BAX and downregulating the anti-apoptotic protein BCL-2 thereby activating Caspase-3. Our study reports the first mechanistic anticancer evaluation of the compounds isolated from the rhizomes of Trillium govanianumwith remarkable activity in the desired micro molar range. Graphical abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=108 SRC="FIGDIR/small/537170v1_ufig1.gif" ALT="Figure 1"> View larger version (29K): org.highwire.dtl.DTLVardef@14d9769org.highwire.dtl.DTLVardef@10f7658org.highwire.dtl.DTLVardef@22a38borg.highwire.dtl.DTLVardef@1f0b28_HPS_FORMAT_FIGEXP M_FIG C_FIG
- organism: human
- assay: metabolomics
- research focus: drug response / drug discovery
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Macrocybin, a mushroom natural triglyceride, reduces tumor growth in vitro and in vivo through caveolin-mediated interference with the actin cytoskeleton
M. Vilarino, J. Garcia-Sanmartin, … A. Martinez·bioRxiv·Dec 10, 2020
- Antitumor Effects Of Phytochemicals Of Hot Three Plants On Gastric Adenocarcinoma
N. Ragchaasuren, M. Tumurkhuu, … T. Dalkh·bioRxiv·Nov 21, 2021
- Structural modification of naturally-occurring phenolics as a strategy for developing cytotoxic molecules towards cancer cells
P. A. Olim, R. B. Pereira, … D. M. Pereira·Archiv der PharmaziePeer-reviewed·Oct 11, 2023
- C19 trityl and silyl andrographolide analogs exhibit in vitro anticancer activity in murine cancer models
Rushika Raval, Ruirui Liu, … Edward Njoo·bioRxiv·Oct 30, 2026
- Cold Vacuum Extracts of Double Cherry Blossom (Gosen-Sakura) Leaves Show Antitumor Activity
R. Rakwal, J. Shibato, … S. Shioda·bioRxiv·Feb 16, 2019
- Synergistic anticancer effect of combined use of (plumbagin, cis-Isoshinanolone, 3-O-β-glucopyranosyl plumbagic acid) isolated from Plumbago zeylanica, induces cell death through apoptosis in human HepG2 cancer cells
Thiruchenduran Mohana, Navin Alukkathara Vijayan, … Sivasitamparam Niranjali Devaraj·bioRxiv·Mar 21, 2025